1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow CC 401: new trials by email Literature Review of CC 401 trials Research Report on CC 401
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia CC-401 - Myeloid Leukemia | Phase 1 | Terminated | Celgene Corporation | 36 | 2005-10-01 | 2007-05-15 |
Leukemia (1) · Leukemia, Myeloid (1)
United States (1)